Randy L. Scherer, Ph.D. - Publications
Affiliations: | 2010 | Vanderbilt University, Nashville, TN |
Area:
Nanotechnology, Biomedical EngineeringYear | Citation | Score | |||
---|---|---|---|---|---|
2015 | Samuelson LE, Scherer RL, VanSaun MN, Fan KH, Dozier EA, Carter KJ, Koyama T, Shyr Y, Aschner M, Stanwood GD, Bornhop DJ, Matrisian LM, McIntyre JO. New tools for the quantitative assessment of prodrug delivery and neurotoxicity. Neurotoxicology. 47: 88-98. PMID 25732874 DOI: 10.1016/J.Neuro.2015.02.005 | 0.553 | |||
2013 | Samuelson LE, Scherer RL, Matrisian LM, McIntyre JO, Bornhop DJ. Synthesis and in vitro efficacy of MMP9-activated NanoDendrons. Molecular Pharmaceutics. 10: 3164-74. PMID 23750801 DOI: 10.1021/Mp4002206 | 0.603 | |||
2011 | Yu SS, Scherer RL, Ortega RA, Bell CS, O'Neil CP, Hubbell JA, Giorgio TD. Enzymatic- and temperature-sensitive controlled release of ultrasmall superparamagnetic iron oxides (USPIOs) Journal of Nanobiotechnology. 9. PMID 21352596 DOI: 10.1186/1477-3155-9-7 | 0.377 | |||
2010 | McIntyre JO, Scherer RL, Matrisian LM. Near-infrared optical proteolytic beacons for in vivo imaging of matrix metalloproteinase activity. Methods in Molecular Biology (Clifton, N.J.). 622: 279-304. PMID 20135290 DOI: 10.1007/978-1-60327-299-5_18 | 0.632 | |||
2008 | Scherer RL, VanSaun MN, McIntyre JO, Matrisian LM. Optical imaging of matrix metalloproteinase-7 activity in vivo using a proteolytic nanobeacon. Molecular Imaging. 7: 118-31. PMID 19123982 DOI: 10.2310/7290.2008.00010 | 0.617 | |||
2008 | Scherer RL, McIntyre JO, Matrisian LM. Imaging matrix metalloproteinases in cancer. Cancer Metastasis Reviews. 27: 679-90. PMID 18465089 DOI: 10.1007/S10555-008-9152-9 | 0.629 | |||
Show low-probability matches. |